Showing results (31-40 of 148) with videos related to
Sort By:
Pageof 15
Carcinogenesis|February 7, 2012
Promoter methylation of aminopeptidase N/CD13 in malignant melanomaJens Wulfänger, Heike Schneider, Peter Wild, et al.Seminars in Cancer Biology|September 12, 2021
Extracellular vesicles in anti-tumor immunityElisabetta Vergani, Elena Daveri, Viviana Vallacchi, et al.Journal of Leukocyte Biology|October 26, 2005
Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediatorsMarco A Cassatella, Veronica Huber, Federica Calzetti, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cellsAline Martayan, Leonardo Sibilio, Elisa Tremante, et al.BMC Bioinformatics|October 28, 2018
A novel computational method for automatic segmentation, quantification and comparative analysis of immunohistochemically labeled tissue sectionsElena Casiraghi, Veronica Huber, Marco Frasca, et al.Cancer Research|September 20, 2006
Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytesRoberta Valenti, Veronica Huber, Paola Filipazzi, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigensDiego Tosi, Roberta Valenti, Agata Cova, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccinePaola Filipazzi, Roberta Valenti, Veronica Huber, et al.Cancer Research|April 3, 2003
Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analoguesMatteo G Carrabba, Chiara Castelli, Markus J Maeurer, et al.European Journal of Immunology|March 21, 2003
Adoptive transfer of an anti-MART-1(27-35)-specific CD8+ T cell clone leads to immunoselection of human melanoma antigen-loss variants in SCID miceFrancesco Lozupone, Licia Rivoltini, Francesca Luciani, et al.Pageof 15